Stay updated on Fruquintinib and Sintilimab in Advanced Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Fruquintinib and Sintilimab in Advanced Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fruquintinib and Sintilimab in Advanced Solid Tumors Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page’s footer revision/version indicator was updated from **v3.5.2** to **v3.5.3**, reflecting a minor platform or release change rather than an update to the clinical trial information.
    Difference
    0.1%
    Check dated 2026-04-24T06:24:39.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:42:59.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    38 days ago
    Change Detected
    Summary
    The page now shows revision v3.5.0. The previous revision v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-19T04:48:45.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.1%
    Check dated 2026-03-12T00:38:50.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; an older notice about government funding and the previous Revision: v3.4.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T12:01:05.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    A government funding lapse notice was added, indicating NIH operations status, and the site revision tag was updated to v3.4.1 (replacing v3.4.0).
    Difference
    0.4%
    Check dated 2026-02-04T06:36:38.000Z thumbnail image

Stay in the know with updates to Fruquintinib and Sintilimab in Advanced Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fruquintinib and Sintilimab in Advanced Solid Tumors Clinical Trial page.